These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 27553713)

  • 1. Oncogenic and tumor-suppressive mouse models for breast cancer engaging HER2/neu.
    Fry EA; Taneja P; Inoue K
    Int J Cancer; 2017 Feb; 140(3):495-503. PubMed ID: 27553713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical applications of mouse models for breast cancer engaging HER2/neu.
    Fry EA; Taneja P; Inoue K
    Integr Cancer Sci Ther; 2016; 3(5):593-603. PubMed ID: 28133539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Critical roles of DMP1 in human epidermal growth factor receptor 2/neu-Arf-p53 signaling and breast cancer development.
    Taneja P; Maglic D; Kai F; Sugiyama T; Kendig RD; Frazier DP; Willingham MC; Inoue K
    Cancer Res; 2010 Nov; 70(22):9084-94. PubMed ID: 21062982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Generation and comparison of two genetically engineered mouse models of ErbB2/Neu positive-PTEN deficient breast cancer].
    Wang QF; Ding H; Liu BR; Zhang K
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2014 Jul; 43(4):427-33. PubMed ID: 25187457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting HER2: recent developments and future directions for breast cancer patients.
    Wang SC; Zhang L; Hortobagyi GN; Hung MC
    Semin Oncol; 2001 Dec; 28(6 Suppl 18):21-9. PubMed ID: 11774202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Taspase1 cleaves MLL1 to activate cyclin E for HER2/neu breast tumorigenesis.
    Dong Y; Van Tine BA; Oyama T; Wang PI; Cheng EH; Hsieh JJ
    Cell Res; 2014 Nov; 24(11):1354-66. PubMed ID: 25267403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumoral actions of the anti-obesity drug orlistat (XenicalTM) in breast cancer cells: blockade of cell cycle progression, promotion of apoptotic cell death and PEA3-mediated transcriptional repression of Her2/neu (erbB-2) oncogene.
    Menendez JA; Vellon L; Lupu R
    Ann Oncol; 2005 Aug; 16(8):1253-67. PubMed ID: 15870086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis.
    Cabodi S; Tinnirello A; Di Stefano P; Bisar├▓ B; Ambrosino E; Castellano I; Sapino A; Arisio R; Cavallo F; Forni G; Glukhova M; Silengo L; Altruda F; Turco E; Tarone G; Defilippi P
    Cancer Res; 2006 May; 66(9):4672-80. PubMed ID: 16651418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor suppressor ARF inhibits HER-2/neu-mediated oncogenic growth.
    Zhang Y; Yang HY; Zhang XC; Yang H; Tsai M; Lee MH
    Oncogene; 2004 Sep; 23(42):7132-43. PubMed ID: 15273726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conditional knockout of SHP2 in ErbB2 transgenic mice or inhibition in HER2-amplified breast cancer cell lines blocks oncogene expression and tumorigenesis.
    Zhao H; Martin E; Matalkah F; Shah N; Ivanov A; Ruppert JM; Lockman PR; Agazie YM
    Oncogene; 2019 Mar; 38(13):2275-2290. PubMed ID: 30467378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Her-2/neu overexpression induces NF-kappaB via a PI3-kinase/Akt pathway involving calpain-mediated degradation of IkappaB-alpha that can be inhibited by the tumor suppressor PTEN.
    Pianetti S; Arsura M; Romieu-Mourez R; Coffey RJ; Sonenshein GE
    Oncogene; 2001 Mar; 20(11):1287-99. PubMed ID: 11313873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of periostin/OSF-2 in ErbB2/Neu-driven tumors results in androgen receptor-positive molecular apocrine-like tumors with reduced Notch1 activity.
    Sriram R; Lo V; Pryce B; Antonova L; Mears AJ; Daneshmand M; McKay B; Conway SJ; Muller WJ; Sabourin LA
    Breast Cancer Res; 2015 Jan; 17(1):7. PubMed ID: 25592291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ADAMTS18 deficiency associates extracellular matrix dysfunction with a higher risk of HER2-positive mammary tumorigenesis and metastasis.
    Nie J; Dang S; Zhu R; Lu T; Zhang W
    Breast Cancer Res; 2024 Jan; 26(1):19. PubMed ID: 38287441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequent overexpression of AMAP1, an Arf6 effector in cell invasion, is characteristic of the MMTV-PyMT rather than the MMTV-Neu human breast cancer model.
    Otsuka Y; Oikawa T; Yoshino H; Hashimoto S; Handa H; Yamamoto H; Hashimoto A; Sabe H
    Cell Commun Signal; 2018 Jan; 16(1):1. PubMed ID: 29329590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effect of HER2/neu overexpression on p53 gene expression, cell proliferation and sensitivity to gamma-irradiation via the PI3K/Akt pathway in breast cancer cell MCF7].
    Zheng L; Ren JQ; Chen Q; Zhang HP; Zhu HG
    Zhonghua Zhong Liu Za Zhi; 2004 Oct; 26(10):594-7. PubMed ID: 15634518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cooperation between Dmp1 loss and cyclin D1 overexpression in breast cancer.
    Zhu S; Mott RT; Fry EA; Taneja P; Kulik G; Sui G; Inoue K
    Am J Pathol; 2013 Oct; 183(4):1339-1350. PubMed ID: 23938323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced androgen receptor expression accelerates the onset of ERBB2 induced breast tumors in female mice.
    Hodgson MC; Vanostran G; Alghamdi S; Poppiti RJ; Agoulnik AI; Agoulnik IU
    PLoS One; 2013; 8(4):e60455. PubMed ID: 23593223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein-tyrosine phosphatase 1B is required for HER2/Neu-induced breast cancer.
    Bentires-Alj M; Neel BG
    Cancer Res; 2007 Mar; 67(6):2420-4. PubMed ID: 17347513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased erbB3 promotes erbB2/neu-driven mammary tumor proliferation and co-targeting of erbB2/erbB3 receptors exhibits potent inhibitory effects on breast cancer cells.
    Lyu H; Huang J; Edgerton SM; Thor AD; He Z; Liu B
    Int J Clin Exp Pathol; 2015; 8(6):6143-56. PubMed ID: 26261492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dmp1╬▒ inhibits HER2/neu-induced mammary tumorigenesis.
    Fry EA; Taneja P; Maglic D; Zhu S; Sui G; Inoue K
    PLoS One; 2013; 8(10):e77870. PubMed ID: 24205004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.